HIMSSCast: Should telehealth be specialized or a one-stop shop?

NurX CEO Varsha Rao on the female-focused telehealth company's expansion from contraception to dermatology, migraines and more.
By Jonah Comstock
01:19 pm
Podcast guest Varsha Rao, CEO of NurX

NurX CEO Varsha Rao joins host Jonah Comstock and MobiHealthNews Managing Editor Laura Lovett to discuss her telehealth company's journey from a laser focus on contraception to a broader play for women's (and men's) health that includes dermatology and migraines.

Along the way, we also discuss broader trends in telehealth, the challenges of femtech and NurX's foray into COVID-19 testing. 

Like what you hear? Subscribe to the podcast on Apple PodcastsSpotify or Google Play!




Talking points:

  • NurX’s story
  • What does it mean to be a female-focused telehealth company?
  • Following a patient through their lifelong patient journey
  • How NurX got into home COVID-19 testing
  • Digital health companies as service companies
  • Challenges and advantages of a woman-led startup
  • Things men don’t understand about contraception
  • NurX’s road map for new products, and COVID-19’s effect on it
  • Should telehealth be a one-stop shop?
  • The advantages of asynchronous telemedicine
  • Dealing with stigma in healthcare
  • The future of digital health and telehealth
  • NurX’s role in COVID-19 testing
  • What’s next for NurX?
  • Varsha’s advice for healthcare startups

More about this episode:

Nurx CEO on what's next for women's health in 2021

Nurx sets sights on the migraine and headache space

Nurx collects another $22.5M for birth control & STI treatment deliveries

At-home COVID-19 testing services pump the brakes after FDA warns of 'fraudulent' kits

EverlyWell, Nurx to release at-home COVID-19 test kits within a week

Nurx gets another $52 million to deliver mail-order birth control, PrEP, STI test kits

Nurx adds STI testing to its mail-order product suite

Nurx gets $36M for telemedicine for birth control, adds Chelsea Clinton to board

Nurx raises $5.3M for app-based birth control and PrEP service



The latest news in digital health delivered daily to your inbox.

Thank you for subscribing!
Error! Something went wrong!